Economic burden of chemotherapy-treated recurrent and/or metastatic squamous cell carcinoma of the head and neck in France: real-world data from the permanent sample of national health insurance beneficiaries-Reference-Cited by-同舟云学术

Economic burden of chemotherapy-treated recurrent and/or metastatic squamous cell carcinoma of the head and neck in France: real-world data from the permanent sample of national health insurance beneficiaries

Published:2019-04-02 Issue:7 Volume:22 Page:698-705
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Lafuma Antoine¹,Cotté François-Emery²,Le Tourneau Christophe³⁴⁵,Emery Corinne¹,Gaudin Anne-Françoise²,Torreton Elodie¹,Gourmelen Julie⁶,Bonastre Julia⁷⁸

Affiliation:

1. Cemka, Bourg-la-Reine, France;

2. Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France;

3. Department of Drug Development and Innovation (D3i), Paris & Saint-Cloud, France;

4. INSERM U900 Research Unit, Saint-Cloud, France;

5. Paris-Saclay University, France;

6. UMS 011, UVSQ, INSERM, Villejuif, France;

7. Gustave Roussy, Université Paris-Saclay, Service de Biostatistique et d’Epidémiologie, Villejuif, France;

8. INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif, France

Funder

Bristol-Myers Squibb

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://tandfonline.com/doi/pdf/10.1080/13696998.2019.1594837

Reference31 articles.

1. Morphology & Grade | SEER Training [Internet]. National Cancer Institute – SEER Training Modules. 2018. [cited 2018 Nov 16]. Available from: https://training.seer.cancer.gov/lung/abstract-code-stage/morphology

2. National Cancer Institute – Oral Cavity Pharynx Cancer – Cancer Stat Facts [Internet]. Surveillance, Epidemiology, and End Results Program; 2015 [cited 2018 Nov 2]. Available from: https://seer.cancer.gov/statfacts/html/oralcav.html

3. Jéhannin-Ligier K, Dantony E, Bossard N, et al. Projection de l’incidence et de la mortalité par cancer en France métropolitaine en 2017 – rapport technique [Incidence and mortality projection by cancer in metropolitan France in 2017 – technical report] [Internet]. Saint-Maurice: Santé Publique France; 2017. 80p. [cited 2018 Nov 16]. Available from: http://www.e-cancer.fr/

4. Haute Autorité de Santé (HAS). ALD n°30 – Cancer des voies aéro-digestives supérieures [ALD n°30 – Upper aero-digestive tract cancer] [Internet]. Saint-Denis La Plaine: HAS; 2012. [cited 2018 Nov 16]. Available from: http://www.has-sante.fr/portail/jcms/c_892164/fr/ald-n-30-cancer-des-voies-aero-digestives-superieures

5. Leone N, Voirin N, Roche L, et al. Projection de l’incidence et de la mortalité par cancer en France métropolitaine en 2015 – rapport technique [Incidence and mortality projection by cancer in metropolitan France in 2015 – technical report] [Internet]. Saint-Maurice: Institut de Veille Sanitaire; 2015. [cited 2018 Nov 16]. Available from: http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Projection-de-l-incidence-et-de-la-mortalite-par-cancer-en-France-metropolitaine-en-2015-Rapport-technique

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost of Illness of Head and Neck Cancer in Sweden;Value in Health;2024-04

2. Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis;European Journal of Nuclear Medicine and Molecular Imaging;2022-05-24

3. The cost of oral cancer: A systematic review;PLOS ONE;2022-04-21

4. Real-World Treatment Patterns and Outcomes in Patients with Head and Neck Cancer: Point-in-Time Survey of Oncologists in Italy and Spain;Advances in Therapy;2021-07-28

5. Direct costs associated with the management of mucositis: A systematic review;Oral Oncology;2021-07